Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects:

Protocol for blood culture during the control period. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of sterile blood transfer devices. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of skin disinfection swab sets in the hospital. by Miki Doi (15347878)

Subjects:

Organisms causing bacterial culture contamination and the contamination rate for each organism during the study period. by Miki Doi (15347878)

Subjects:

Swab cultures around the hole of a needle-removing device. by Miki Doi (15347878)

Subjects:

Comparison of the contaminant isolation rate between the control and bundle periods in August and September and in the remaining 10 months. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate between the control and bundle periods according to the evaluation method. by Miki Doi (15347878)

Subjects:

S1 Data - by Miki Doi (15347878)

Subjects:

S1 Fig - by Miki Doi (15347878)

Subjects:

Comparison of the proportion of each organism among contaminants between the control and bundle periods. by Miki Doi (15347878)

Subjects:

IRE1 depletion downregulates multiple cell cycle proteins in synchronized cells. by Iratxe Zuazo-Gaztelu (21071939)

Subjects:

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

Subjects: